Barriers of General Practitioner Regarding Helicobacter Pylori.

December 7, 2025 updated by: Mohanad Abd_Elaleem Sayed Amer, Assiut University

Knowledge, Attitude, Practices and Barriersof General Practitioner RegardingHelicobacter Pylori Diagnosis andTreatment

This study aims to evaluate the knowledge, attitudes, and clinical practices of general practitioners regarding the diagnosis and treatment of Helicobacter pylori infection. The study also seeks to identify the main barriers that prevent proper management of the condition. The central hypothesis is that gaps in knowledge and challenges in clinical practice contribute to variations in how general practitioners diagnose and treat H. pylori infection.

Study Overview

Status

Not yet recruiting

Conditions

Detailed Description

This study explores the knowledge, attitudes, and practices of general practitioners regarding the diagnosis and treatment of Helicobacter pylori infection. It also examines the barriers that may affect appropriate clinical decision-making in managing this common gastrointestinal condition. By assessing physicians' understanding of recommended diagnostic techniques, treatment regimens, and follow-up strategies, the study aims to identify areas where education or system-level improvements may be needed.

The study hypothesizes that insufficient knowledge of current guidelines, limited access to diagnostic tests, and patient-related or system-related barriers contribute to inconsistent management of H. pylori infection among general practitioners. The findings may help inform future training programs and improve patient care outcomes.

Study Type

Observational

Enrollment (Estimated)

300

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Mohamed Abdel-Sabour Mohamed Mekky Abdel-Sabour Mohamed Mekky
  • Phone Number: +20 10 12569456
  • Email: m.mekky@aun.edu.eg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

cross-sectional, observational study.

Conducted in primary health care centers,

outpatient clinics, and general hospitals in Up

Egypt (e.g., Assiut, Sohag, Qena, Minya, Luxo

Aswan).

Description

Inclusion Criteria:

- Licensed general practitioners actively working primary health care centers, outpatients clinics and general hospitals in Upper Egypt( Assuit, Minya, Sohag, Qena, luxor and Aswan).

Exclusion Criteria:

  • Specialists in gastroenterology.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Demographic , knowledge , Practices , attitude and barriers
Section A: demographic data (age, gender, years of experience, workplace) Section B: knowledge (transmission, symptoms, diagnostic methods,. treatment guidelines) Section C: attitude (perceived importance, confidence in diagnosis/treatment) Section D: practice (frequency of testing, treatment regimen used). Section E: barriers (e.g., Lack of resources, guidelines, time constraints, patient adherence)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Knowledge
Time Frame: After history and examination by 1 hour.
Level of knowledge about H. pylori infection among General Practitioners" "Measured using a questionnaire of X items (e.g., 15 multiple-choice questions). The total knowledge score will be calculated as the percentage of correct answers."
After history and examination by 1 hour.
Attitudes
Time Frame: After history and examination by 1 hour.
Attitudes of General Practitioners towards diagnosis and treatment of H. pylori infection" "Measured using an X-point Likert scale (e.g., 5-point) on Y items (e.g., 10 statements). A mean score will be calculated for each participant."
After history and examination by 1 hour.
Practices
Time Frame: After history and examination by 1 hour.
Clinical practices of General Practitioners in managing H. pylori infection" "Measured using questions regarding frequency of testing and types of treatment regimens prescribed. Percentages for each practice will be calculated."
After history and examination by 1 hour.
Perceived Barriers
Time Frame: After history and examination by 1 hour.
Barriers reported by General Practitioners in diagnosing and treating H. pylori infection" "Measured using a checklist or Likert scale containing specific barriers (e.g., lack of resources, time constraints, guideline clarity). Frequencies or scores for each barrier will be calculated."
After history and examination by 1 hour.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

December 15, 2025

Primary Completion (Estimated)

October 15, 2026

Study Completion (Estimated)

December 15, 2026

Study Registration Dates

First Submitted

September 29, 2025

First Submitted That Met QC Criteria

December 7, 2025

First Posted (Actual)

December 16, 2025

Study Record Updates

Last Update Posted (Actual)

December 16, 2025

Last Update Submitted That Met QC Criteria

December 7, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • Helicobacter Pylori

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on H.Pylori Infection

Subscribe